RANI
Rani Therapeutics Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.87
+1.54%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 8.15x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.55x
- Price / sales
- 20.48x
- Price / cash flow
- -4.92x
Enterprise value
- Enterprise value
- $58.8M
- EV / sales
- 12.05x
- EV / EBITDA
- -1.83x
- EV / EBIT
- -1.78x
- Market cap
- $99.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026